KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Accumulated Expenses (2016 - 2026)

Lam Research has reported Accumulated Expenses over the past 17 years, most recently at $2.1 billion for Q1 2026.

  • Quarterly Accumulated Expenses rose 3.78% to $2.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Mar 2026, up 3.78% year-over-year, with the annual reading at $2.4 billion for FY2025, 32.88% up from the prior year.
  • Accumulated Expenses was $2.1 billion for Q1 2026 at Lam Research, down from $2.3 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $2.4 billion in Q3 2025 and troughed at $1.6 billion in Q1 2022.
  • The 5-year median for Accumulated Expenses is $2.0 billion (2023), against an average of $2.0 billion.
  • Biggest five-year swings in Accumulated Expenses: dropped 10.38% in 2024 and later soared 32.88% in 2025.
  • Tracing LRCX's Accumulated Expenses over 5 years: stood at $2.1 billion in 2022, then decreased by 4.47% to $2.0 billion in 2023, then grew by 6.08% to $2.1 billion in 2024, then rose by 8.18% to $2.3 billion in 2025, then fell by 8.47% to $2.1 billion in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $2.1 billion, $2.3 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.